{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:38:59Z","timestamp":1792712339048,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-78085-9","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:45:58Z","timestamp":1790214358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surface-displayed cholesterol enhances penetration and anti-tumor activity of a platinum nanodrug by targeting NPC1L1-expressing cancer associated fibroblasts"],"prefix":"10.1038","volume":"17","author":[{"given":"Peiyi","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifeng","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-8264","authenticated-orcid":false,"given":"Xiaorui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"78085_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41551-019-0405-4","volume":"3","author":"QL Liang","year":"2019","unstructured":"Liang, Q. L. et al. The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency. Nat. Biomed. Eng. 3, 729\u2013740 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"78085_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","volume":"19","author":"S Sindhwani","year":"2020","unstructured":"Sindhwani, S. et al. The entry of nanoparticles into solid tumours. Nat. Mater. 19, 566\u2013575 (2020).","journal-title":"Nat. Mater."},{"key":"78085_CR3","doi-asserted-by":"crossref","unstructured":"Challenging paradigms in tumour drug delivery. Nat. Mater. 19, 477 (2020).","DOI":"10.1038\/s41563-020-0676-x"},{"key":"78085_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119902","volume":"240","author":"Q Zhou","year":"2020","unstructured":"Zhou, Q. et al. Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: the current status and transcytosis strategy. Biomaterials 240, 119902 (2020).","journal-title":"Biomaterials"},{"key":"78085_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41563-020-0672-1","volume":"19","author":"S Pandit","year":"2020","unstructured":"Pandit, S., Dutta, D. & Nie, S. Active transcytosis and new opportunities for cancer nanomedicine. Nat. Mater. 19, 478\u2013480 (2020).","journal-title":"Nat. Mater."},{"key":"78085_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61434-5","volume":"16","author":"YY Liu","year":"2025","unstructured":"Liu, Y. Y. et al. Unlocking tumor barrier: annexin A2-mediated transcytosis boosts drug delivery in pancreatic and breast tumors. Nat. Commun. 16, 6531 (2025).","journal-title":"Nat. Commun."},{"key":"78085_CR7","doi-asserted-by":"publisher","first-page":"114480","DOI":"10.1016\/j.addr.2022.114480","volume":"189","author":"Q Zhou","year":"2022","unstructured":"Zhou, Q. et al. Transcytosis-enabled active extravasation of tumor nanomedicine. Adv. Drug Deliv. Rev. 189, 114480 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"78085_CR8","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1073\/pnas.1522080113","volume":"113","author":"HJ Li","year":"2016","unstructured":"Li, H. J. et al. Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy. Proc. Natl Acad. Sci. USA 113, 4164\u20134169 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"78085_CR9","doi-asserted-by":"publisher","first-page":"2209765","DOI":"10.1002\/adma.202209765","volume":"35","author":"F Duan","year":"2023","unstructured":"Duan, F. et al. Thermo-pH-sensitive polymer conjugated glucose oxidase for tumor-selective starvation-oxidation-immune therapy. Adv. Mater. 35, 2209765 (2023).","journal-title":"Adv. Mater."},{"key":"78085_CR10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","volume":"14","author":"Q Zhou","year":"2019","unstructured":"Zhou, Q. et al. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy. Nat. Nanotechnol. 14, 799\u2013809 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"78085_CR11","doi-asserted-by":"publisher","first-page":"6753","DOI":"10.1021\/acsnano.6b02326","volume":"10","author":"HJ Li","year":"2016","unstructured":"Li, H. J. et al. Smart superstructures with ultrahigh pH-sensitivity for targeting acidic tumor microenvironment: instantaneous size switching and improved tumor penetration. ACS Nano 10, 6753\u20136761 (2016).","journal-title":"ACS Nano"},{"key":"78085_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54382-z","volume":"15","author":"B Li","year":"2024","unstructured":"Li, B. et al. -Glutamyl transpeptidase-activable nanoprobe crosses the blood-brain barrier for immuno-sonodynamic therapy of glioma. Nat. Commun. 15, 10418 (2024).","journal-title":"Nat. Commun."},{"key":"78085_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202506038","volume":"64","author":"R Sun","year":"2025","unstructured":"Sun, R. et al. Dual enzyme-responsive polymer-drug conjugates induce diverse cells mutual transcytosis to achieve deep pancreatic tumor penetration. Angew. Chem. Int. Ed. 64, e202506038 (2025).","journal-title":"Angew. Chem. Int. Ed."},{"key":"78085_CR14","doi-asserted-by":"publisher","first-page":"2401304","DOI":"10.1002\/adma.202401304","volume":"36","author":"YX Zhang","year":"2024","unstructured":"Zhang, Y. X. et al. Dendritic polymer-based nanomedicines remodel the tumor stroma: improve drug penetration and enhance antitumor immune response. Adv. Mater. 36, 2401304 (2024).","journal-title":"Adv. Mater."},{"key":"78085_CR15","doi-asserted-by":"publisher","first-page":"2214937","DOI":"10.1002\/adfm.202214937","volume":"33","author":"HY Chen","year":"2023","unstructured":"Chen, H. Y. et al. Transcytosis mediated deep tumor penetration for enhanced chemotherapy and immune activation of pancreatic cancer. Adv. Funct. Mater. 33, 2214937 (2023).","journal-title":"Adv. Funct. Mater."},{"key":"78085_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"FL Wu","year":"2021","unstructured":"Wu, F. L. et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct. Target. Ther. 6, 218 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"78085_CR17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"DK Yang","year":"2023","unstructured":"Yang, D. K., Liu, J., Qian, H. & Zhuang, Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp. Mol. Med. 55, 1322\u20131332 (2023).","journal-title":"Exp. Mol. Med."},{"key":"78085_CR18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen, Y., McAndrews, K. M. & Kalluri, R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat. Rev. Clin. Oncol. 18, 792\u2013804 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"78085_CR19","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cell.2023.03.016","volume":"186","author":"Y Chhabra","year":"2023","unstructured":"Chhabra, Y. & Weeraratna, A. T. Fibroblasts in cancer: unity in heterogeneity. Cell 186, 1580\u20131609 (2023).","journal-title":"Cell"},{"key":"78085_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer 16, 582\u2013598 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"78085_CR21","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1021\/acsnano.4c16329","volume":"19","author":"SY Xu","year":"2025","unstructured":"Xu, S. Y. et al. Nitric oxide-producing multiple functional nanoparticle remodeling tumor microenvironment for synergistic photodynamic immunotherapy against hypoxic tumor. ACS Nano 19, 6371\u20136387 (2025).","journal-title":"ACS Nano"},{"key":"78085_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"XM Chen","year":"2019","unstructured":"Chen, X. M. & Song, E. W. Turning foes to friends: targeting cancer-associated fibroblasts. Nat. Rev. Drug Discov. 18, 99\u2013115 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"78085_CR23","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin, C. H., Rubin, K. & Pietras, K. & \u00d6stman, A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat. Rev. Cancer 4, 806\u2013813 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"78085_CR24","doi-asserted-by":"publisher","first-page":"2301257","DOI":"10.1002\/adma.202301257","volume":"35","author":"DX Guo","year":"2023","unstructured":"Guo, D. X. et al. Targeted reprogramming of vitamin B3 metabolism as a nanotherapeutic strategy towards chemoresistant cancers. Adv. Mater. 35, 2301257 (2023).","journal-title":"Adv. Mater."},{"key":"78085_CR25","doi-asserted-by":"publisher","first-page":"2423200","DOI":"10.1002\/adfm.202423200","volume":"35","author":"XY Chen","year":"2025","unstructured":"Chen, X. Y. et al. Fibroblast-activation protein targeted immunostimulant to provoke colorectal cancer immunity through photodynamic depleting and chemotherapeutic silencing of cancer associated fibroblasts. Adv. Funct. Mater. 35, 2423200 (2025).","journal-title":"Adv. Funct. Mater."},{"key":"78085_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol. Cancer 22, 159 (2023).","journal-title":"Mol. Cancer"},{"key":"78085_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-017-0448-5","volume":"10","author":"D von Ahrens","year":"2017","unstructured":"von Ahrens, D., Bhagat, T. D., Nagrath, D., Maitra, A. & Verma, A. The role of stromal cancer-associated fibroblasts in pancreatic cancer. J. Hematol. Oncol. 10, 76 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"78085_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa, A. et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell 33, 463\u2013479 (2018).","journal-title":"Cancer Cell"},{"key":"78085_CR29","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.ccell.2022.10.015","volume":"40","author":"XW Liu","year":"2022","unstructured":"Liu, X. W. et al. CD16+fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition. Cancer Cell 40, 1341\u20131357 (2022).","journal-title":"Cancer Cell"},{"key":"78085_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC \u00d6zdemir","year":"2014","unstructured":"\u00d6zdemir, B. C. et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25, 719\u2013734 (2014).","journal-title":"Cancer Cell"},{"key":"78085_CR31","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.1021\/acsnano.5b03569","volume":"9","author":"S Mitragotri","year":"2015","unstructured":"Mitragotri, S. et al. Accelerating the translation of nanomaterials in biomedicine. ACS Nano 9, 6644\u20136654 (2015).","journal-title":"ACS Nano"},{"key":"78085_CR32","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).","journal-title":"Nat. Rev. Mater."},{"key":"78085_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo, J., Yang, H. Y. & Song, B. L. Mechanisms and regulation of cholesterol homeostasis. Nat. Rev. Mol. Cell Biol. 21, 225\u2013245 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"78085_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42179-5","volume":"14","author":"J Xiao","year":"2023","unstructured":"Xiao, J. et al. Bile acids-mediated intracellular cholesterol transport promotes intestinal cholesterol absorption and NPC1L1 recycling. Nat. Commun. 14, 6469 (2023).","journal-title":"Nat. Commun."},{"key":"78085_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nm.3417","volume":"20","author":"PS Li","year":"2014","unstructured":"Li, P. S. et al. The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1. Nat. Med. 20, 80\u201386 (2014).","journal-title":"Nat. Med."},{"key":"78085_CR36","doi-asserted-by":"publisher","first-page":"217493","DOI":"10.1016\/j.canlet.2025.217493","volume":"612","author":"XA You","year":"2025","unstructured":"You, X. A. et al. Dual targeting PPAR\u03b1 and NPC1L1 metabolic vulnerabilities blocks tumorigenesis. Cancer Lett. 612, 217493 (2025).","journal-title":"Cancer Lett."},{"key":"78085_CR37","volume":"6","author":"R Zi","year":"2025","unstructured":"Zi, R. et al. NPC1L1 on pancreatic adenocarcinoma cell functions as a two-pronged checkpoint against antitumor activity. Innovation 6, 100783 (2025).","journal-title":"Innovation"},{"key":"78085_CR38","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/j.celrep.2017.11.003","volume":"21","author":"R Nicolle","year":"2017","unstructured":"Nicolle, R. et al. Pancreatic adenocarcinoma therapeutic targets revealed by tumor-stroma cross-talk analyses in patient-derived xenografts. Cell Rep. 21, 2458\u20132470 (2017).","journal-title":"Cell Rep."},{"key":"78085_CR39","doi-asserted-by":"publisher","first-page":"40828","DOI":"10.1021\/acsnano.5c10653","volume":"19","author":"GF Miao","year":"2025","unstructured":"Miao, G. F. et al. Tumor-specific delivery of nanomedicines via a nutrient sensing-driven pathway mediated by Niemann-Pick C1-like 1. ACS Nano 19, 40828\u201340849 (2025).","journal-title":"ACS Nano"},{"key":"78085_CR40","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/s43018-025-00997-0","volume":"6","author":"G Miao","year":"2025","unstructured":"Miao, G. et al. Concurrent inhibition of tumor growth and metastasis by a lipidated nanophotosensitizer tracing and disabling tumor extracellular vesicles. Nat. Cancer 6, 1438\u20131457 (2025).","journal-title":"Nat. Cancer"},{"key":"78085_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf0966","volume":"382","author":"A Ferrari","year":"2023","unstructured":"Ferrari, A. et al. Aster-dependent nonvesicular transport facilitates dietary cholesterol uptake. Science 382, eadf0966 (2023).","journal-title":"Science"},{"key":"78085_CR42","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41565-023-01401-7","volume":"18","author":"J Guo","year":"2023","unstructured":"Guo, J. et al. Cell spheroid creation by transcytotic intercellular gelation. Nat. Nanotechnol. 18, 1094\u20131104 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"78085_CR43","doi-asserted-by":"publisher","first-page":"2104125","DOI":"10.1002\/advs.202104125","volume":"9","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Enhancing penetration ability of semiconducting polymer nanoparticles for sonodynamic therapy of large solid tumor. Adv. Sci. 9, 2104125 (2022).","journal-title":"Adv. Sci."},{"key":"78085_CR44","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger, S., Jiang, Q. & Ganesh, K. Metastasis. Cell 186, 1564\u20131579 (2023).","journal-title":"Cell"},{"key":"78085_CR45","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","volume":"25","author":"L Voorwerk","year":"2019","unstructured":"Voorwerk, L. et al. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. Nat. Med. 25, 920\u2013928 (2019).","journal-title":"Nat. Med."},{"key":"78085_CR46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","volume":"16","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi, H. et al. Cancer-associated fibroblasts in gastrointestinal cancer. Nat. Rev. Gastroenterol. Hepatol. 16, 282\u2013295 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"78085_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41420-025-02566-x","volume":"11","author":"H Masuda","year":"2025","unstructured":"Masuda, H. Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review. Cell Death Discov. 11, 341 (2025).","journal-title":"Cell Death Discov."},{"key":"78085_CR48","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/cancers12092652","volume":"12","author":"D Ganguly","year":"2020","unstructured":"Ganguly, D. et al. Cancer-associated fibroblasts: versatile players in the tumor microenvironment. Cancers 12, 2652 (2020).","journal-title":"Cancers"},{"key":"78085_CR49","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi, G. et al. IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 9, 282\u2013301 (2019).","journal-title":"Cancer Discov."},{"key":"78085_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","volume":"10","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Invasion and metastasis in cancer: molecular insights and therapeutic targets. Signal Transduct. Target. Ther. 10, 57 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"78085_CR51","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.3390\/cancers13184720","volume":"13","author":"PJ Asif","year":"2021","unstructured":"Asif, P. J., Longobardi, C., Hahne, M. & Medema, J. P. The role of cancer-associated fibroblasts in cancer invasion and metastasis. Cancers 13, 4720 (2021).","journal-title":"Cancers"},{"key":"78085_CR52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"78085_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ccell.2023.12.002","volume":"42","author":"G Mucciolo","year":"2024","unstructured":"Mucciolo, G. et al. EGFR-activated myofibroblasts promote metastasis of pancreatic cancer. Cancer Cell 42, 101\u2013118.e111 (2024).","journal-title":"Cancer Cell"},{"key":"78085_CR54","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-24-1816","volume":"85","author":"J Zhan","year":"2025","unstructured":"Zhan, J. et al. Targeting LTBP2 derived from cancer-associated fibroblasts sensitizes esophageal squamous cell carcinoma to chemotherapy. Cancer Res. 85, 2412\u20132428 (2025).","journal-title":"Cancer Res."},{"key":"78085_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.trecan.2024.11.005","volume":"11","author":"PSW Cheng","year":"2025","unstructured":"Cheng, P. S. W., Zaccaria, M. & Biffi, G. Functional heterogeneity of fibroblasts in primary tumors and metastases. Trends Cancer 11, 135\u2013153 (2025).","journal-title":"Trends Cancer"},{"key":"78085_CR56","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1021\/acs.langmuir.8b00375","volume":"34","author":"K Kim","year":"2018","unstructured":"Kim, K., Jang, S., Jeon, J., Kang, D. & Sohn, B. H. Fluorescent supracolloidal chains of patchy micelles of diblock copolymers functionalized with fluorophores. Langmuir 34, 4634\u20134639 (2018).","journal-title":"Langmuir"},{"key":"78085_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.eurpolymj.2013.10.015","volume":"50","author":"JQ Liu","year":"2014","unstructured":"Liu, J. Q., Cui, L., Kong, N., Barrow, C. J. & Yang, W. R. RAFT controlled synthesis of graphene\/polymer hydrogel with enhanced mechanical property for pH-controlled drug release. Eur. Polym. J. 50, 9\u201317 (2014).","journal-title":"Eur. Polym. J."},{"key":"78085_CR58","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1039\/C0PY00254B","volume":"2","author":"J Yin","year":"2011","unstructured":"Yin, J., Hu, H. B., Wu, Y. H. & Liu, S. Y. Thermo-and light-regulated fluorescence resonance energy transfer processes within dually responsive microgels. Polym. Chem. 2, 363\u2013371 (2011).","journal-title":"Polym. Chem."},{"key":"78085_CR59","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jconrel.2022.07.016","volume":"349","author":"G Tan","year":"2022","unstructured":"Tan, G. et al. Bioinspired poly(cation-\u03c0) micelles drug delivery platform for improving chemotherapy efficacy. J. Control. Release 349, 486\u2013501 (2022).","journal-title":"J. Control. Release"},{"key":"78085_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36469-1","volume":"14","author":"XD Wen","year":"2023","unstructured":"Wen, X. D. et al. Controlled sequential in situ self-assembly and disassembly of a fluorogenic cisplatin prodrug for cancer theranostics. Nat. Commun. 14, 800 (2023).","journal-title":"Nat. Commun."},{"key":"78085_CR61","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jconrel.2023.11.028","volume":"365","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. J. Control. Release 365, 112\u2013131 (2024).","journal-title":"J. Control. Release"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78085-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78085-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78085-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:57:43Z","timestamp":1792709863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78085-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["78085"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-78085-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"11071"}}